| Name | NAD(P)HX epimerase |
| Description | The product of this gene interacts with apolipoprotein A-I (apoA-I), the major apolipoprotein of high-density lipoproteins (HDLs). It is secreted into some bodily fluids, and its synthesis and secretion are stimulated in vitro by incubating cells with apoA-I. The human genome contains related pseudogenes. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNAXE, formerly known as APOA1BP or AIBP, encodes a highly conserved NAD(P)HX epimerase that plays an essential role in cellular metabolite repair by catalyzing the interconversion of damaged NAD(P)H hydrates. This epimerization prevents the accumulation of toxic by‐products that can impair mitochondrial function and disturb cellular redox balance. In humans, biallelic mutations in NAXE lead to severe neurometabolic disorders characterized by acute‐onset encephalopathy, cerebellar edema, leukoencephalopathy, and rapid neurological deterioration—often triggered by febrile illnesses—with outcomes ranging from progressive disability to early childhood lethality."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its canonical role in NAD(P)HX repair, NAXE (as AIBP) participates in diverse cellular processes that extend its impact on overall cell physiology. By promoting cholesterol efflux from endothelial cells, it modulates membrane lipid raft integrity and attenuates pro‐angiogenic signaling—such as by interfering with VEGFR2 dimerization—thereby serving as a non–cell-autonomous regulator of angiogenesis. Furthermore, NAXE contributes to the regulation of inflammatory responses and even influences mitotic processes by interacting with key proteins and membrane lipids, which has downstream consequences for cell cycle progression and the maintenance of centrosomal structures. Notably, reduced NAXE expression has been linked to pathological states including tumor progression—via increased reactive oxygen species and epithelial–mesenchymal transition—and vascular anomalies such as infantile hemangioma, where impaired NAXE function is associated with aberrant angiogenesis and hypoxia-inducible factor 1α signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ronen Spiegel, Avraham Shaag, Stavit Shalev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Homozygous mutation in the APOA1BP is associated with a lethal infantile leukoencephalopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogenetics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10048-016-0483-3"}], "href": "https://doi.org/10.1007/s10048-016-0483-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27122014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27122014"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Laura S Kremer, Katharina Danhauser, Diran Herebian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NAXE Mutations Disrupt the Cellular NAD(P)HX Repair System and Cause a Lethal Neurometabolic Disorder of Early Childhood."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2016.07.018"}], "href": "https://doi.org/10.1016/j.ajhg.2016.07.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27616477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27616477"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Thomas D Niehaus, Mona Elbadawi-Sidhu, Lili Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moonlighting function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20180223"}], "href": "https://doi.org/10.1042/BSR20180223"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29654173"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29654173"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Dan Yu, Fu-Min Zhao, Xiao-Tang Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Clinical and genetic features of early-onset progressive encephalopathy associated with NAXE gene mutations]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhongguo Dang Dai Er Ke Za Zhi (2018)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30022751"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30022751"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Joanne Trinh, Sophie Imhoff, Marija Dulovic-Mahlow, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00415-019-09640-2"}], "href": "https://doi.org/10.1007/s00415-019-09640-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31745726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31745726"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Pouria Mohammadi, Morteza Heidari, Mahmoud Reza Ashrafi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel homozygous missense variant in the NAXE gene in an Iranian family with progressive encephalopathy with brain edema and leukoencephalopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neurol Belg (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13760-021-01717-y"}], "href": "https://doi.org/10.1007/s13760-021-01717-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34120322"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34120322"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Marwa Maalej, Lamia Sfaihi, Marwa Ammar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a novel homozygous mutation in NAXE gene associated with early-onset progressive encephalopathy by whole-exome sequencing: in silico protein structure characterization, molecular docking, and dynamic simulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogenetics (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10048-022-00696-3"}], "href": "https://doi.org/10.1007/s10048-022-00696-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35819538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35819538"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Swathi Sunil Rao, Gandham Srilakshmi Bhavani, Anil B Jalan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear Mitochondrial Disorder Due to a Variant in NAXE in Two Unrelated Indian Children."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Indian J Pediatr (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12098-023-04495-y"}], "href": "https://doi.org/10.1007/s12098-023-04495-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36773198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36773198"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Longhou Fang, Soo-Ho Choi, Ji Sun Baek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Control of angiogenesis by AIBP-mediated cholesterol efflux."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature12166"}], "href": "https://doi.org/10.1038/nature12166"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23719382"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23719382"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chia-Hua Chou, Joon-Khim Loh, Ming-Chang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AIBp regulates mitotic entry and mitotic spindle assembly by controlling activation of both Aurora-A and Plk1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2015.1066536"}], "href": "https://doi.org/10.1080/15384101.2015.1066536"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26114227"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26114227"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Min Zhang, Guo-Jun Zhao, Kai Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ J (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1253/circj.CJ-17-0877"}], "href": "https://doi.org/10.1253/circj.CJ-17-0877"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29618705"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29618705"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Soo-Ho Choi, Aaron M Wallace, Dina A Schneider, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JCI Insight (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/jci.insight.120519"}], "href": "https://doi.org/10.1172/jci.insight.120519"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30135304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30135304"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jin Sook Lee, Taekyeong Yoo, Moses Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic heterogeneity in Leigh syndrome: Highlighting treatable and novel genetic causes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cge.13713"}], "href": "https://doi.org/10.1111/cge.13713"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32020600"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32020600"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Hann Low, Nigora Mukhamedova, Luciano Dos Santos Aggum Capettini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.120.315037"}], "href": "https://doi.org/10.1161/ATVBAHA.120.315037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32787522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32787522"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Bo Sun, Lei Yu, Cong Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14925"}], "href": "https://doi.org/10.1111/cas.14925"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33932069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33932069"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yongying Jiang, Xingjuan Li, Qin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein A-I Binding Protein Inhibits the Formation of Infantile Hemangioma through Cholesterol-Regulated Hypoxia-Inducible Factor 1α Activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jid.2023.07.030"}], "href": "https://doi.org/10.1016/j.jid.2023.07.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37832842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37832842"}]}]}]}
|
| NCBI Gene ID | 128240 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NAXE has 1,758 functional associations with biological entities spanning 6 categories (chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 49 datasets.
Click the + buttons to view associations for NAXE from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAXE gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NAXE gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NAXE protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NAXE gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NAXE gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with NAXE gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NAXE gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing NAXE protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NAXE protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing NAXE protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NAXE protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of NAXE protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NAXE gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving NAXE gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NAXE gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NAXE gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NAXE gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding NAXE protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NAXE gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NAXE gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing NAXE protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing NAXE protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NAXE gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NAXE gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of NAXE gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NAXE gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NAXE gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NAXE gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with NAXE gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by NAXE gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NAXE gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NAXE gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate NAXE protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NAXE gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NAXE gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NAXE gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NAXE protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NAXE protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving NAXE protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAXE gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAXE gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAXE gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NAXE gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NAXE gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NAXE gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of NAXE gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NAXE protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NAXE protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NAXE protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |